Citation Impact
Citing Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
MRI criteria for MS in patients with clinically isolated syndromes
2010
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
2009 Standout
Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms
2016
Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
2012
Engineered clearing agents for the selective depletion of antigen-specific antibodies
2017
Structural basis of Keap1 interactions with Nrf2
2015
The Therapeutic Potential of HDAC Inhibitors in the Treatment of Multiple Sclerosis
2011
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1
2023 StandoutNobel
Role of nitric oxide in inflammatory diseases
2007 Standout
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
2011
Treatment of Optic Neuritis by Plasma Exchange (Add-On) in Neuromyelitis Optica
2012
MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”
2006
Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey
2008
Myasthenia Gravis
2016 Standout
Acute Disseminated Encephalomyelitis Associated With Influenza A H1N1 Infection
2012
The spectrum of neuromyelitis optica
2007 Standout
Statins: Potential new indications in inflammatory conditions
2006
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
2015
Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis
2006
Update on investigation and management of postinfectious encephalitis
2010
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
2009
Post-infectious encephalitis in adults: Diagnosis and management
2009
Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome
2015
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
2011 Standout
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Revised diagnostic criteria for neuromyelitis optica (NMO)
2007
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Multiple sclerosis
2008 Standout
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
2012
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
2006
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
2012
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Cytokine patterns in patients with cancer: a systematic review
2013 Standout
Herpesvirus-Associated Encephalitis: an Update
2022
Sex differences in autoimmune diseases
2011
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Myasthenia gravis
2019 Standout
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study
2010 Standout
Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues
2018
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression
2006
Hallmarks of Cellular Senescence
2018 Standout
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
Regulation of expression of the novel IL‐1 receptor family members in the mouse brain
2005
Neuromyelitis optica spectrum disorders associated with other autoimmune diseases
2014
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
2007
Sex differences in immune responses
2016 Standout
High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice
2005
Myeloid cells — targets of medication in multiple sclerosis
2016
Imaging of Acute Disseminated Encephalomyelitis
2008
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
2015
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
Effector Functions of Antiaquaporin‐4 Autoantibodies in Neuromyelitis Optica
2009
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Neuroinflammation: the devil is in the details
2016 Standout
Evaluation of aquaporin‐4 antibody assays
2014
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
2008
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
NF-κB in Aging and Disease.
2011 Standout
Risikostratifizierung einer progressiven multifokalen Leukenzephalopathie unter Natalizumab
2011
COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features
2020 Standout
Myasthenia gravis: an update for the clinician
2013
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies
2014
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
2022
Aquaporin‐4 Antibodies (NMO ‐IgG ) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
2013
Multiple Sclerosis
2018 Standout
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
2009
Anti-Glycan Antibodies as Biomarkers for Diagnosis and Prognosis
2006
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Acute Disseminated Encephalomyelitis
2012
Atacicept: targeting B cells in multiple sclerosis
2010
Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein
2005
Atorvastatin treatment modulates p16 promoter methylation to regulate p16 expression
2017
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants
2015
Hematological Problems in Pediatric Intensive Care
2013 Standout
Acute disseminated encephalomyelitis
2007
Physiology of Microglia
2011 Standout
Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan
2017
Works of Til Menge being referenced
Natalizumab Treatment in a Patient With Chronic Inflammatory Demyelinating Polyneuropathy
2010
Acute Disseminated Encephalomyelitis
2005
Disease-Modifying Agents for Multiple Sclerosis
2008
Long-term B-Lymphocyte Depletion With Rituximab in Patients With Relapsing-Remitting Multiple Sclerosis
2009
Acute disseminated encephalomyelitis: an acute hit against the brain
2007
Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination
2004
Quantification and Functional Characterization of Antibodies to Native Aquaporin 4 in Neuromyelitis Optica
2010
Natalizumab and Progressive Multifocal Leukoencephalopathy
2010
Induction of the proinflammatory cytokine interleukin‐18 by axonal injury
2001
Statins — a cure-all for the brain?
2005
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses
2010
Pharmacological Treatment of Early Multiple Sclerosis
2008
Monoclonal Autoantibodies from Patients with Autoimmune Diseases: Specificity, Affinity and Crossreactivity of MAbs Binding to Cytoskeletal and Nucleolar Epitopes, Cartilage Antigens and Mycobacterial Heat-Shock Protein 60
2002
Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis
2005
Dimethyl fumarate in relapsing–remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety
2015
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum
2013
Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis
2021
Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
2013
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis
2006
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children
2010
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR‐20b
2014
Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays
2006